Incidence and risk factors for blood transfusion insimultaneous bilateral total hip arthroplasty

Huang, Qiang、; Pei, Fuxing; wang, xing

doi:10.52312/jdrs.2021.333

Incidence and risk factors for blood transfusion insimultaneous bilateral total hip arthroplasty

Xing WANG, (West China Hospital, Department of Orthopaedic Surgery, China)

Qiang HUANG, (West China Hospital, Department of Orthopaedic Surgery, China)

Fuxing PEI (West China Hospital, Department of Orthopaedic Surgery, China)

Joint diseases and related surgery

1 0

Yıl: 2021 Cilt: 32 Sayı: 3 Sayfa Aralığı: 590 - 597 Metin Dili: İngilizce DOI: 10.52312/jdrs.2021.333 İndeks Tarihi: 29-12-2021

Incidence and risk factors for blood transfusion insimultaneous bilateral total hip arthroplasty

Öz:

Objectives: This study aims to investigate the incidence and riskfactors for blood transfusion in patients undergoing simultaneousbilateral total hip arthroplasty (SimBTHA). Patients and methods: Between January 2011 and June 2021,a total of 341 patients (289 males, 52 females; median age:53 years; range, 43 to 66 years) who underwent SimBTHAwere retrospectively analyzed. The patients were divided intotwo groups as those who did and did not require allogeneicblood transfusion. Univariate and multivariate logistic regressionmodels were used to identify independent risk factors fortransfusion. Results: The incidence of transfusion in SimBTHA was12.9%. We found that a higher preoperative hemoglobin level(odds ratio [OR]: 0.91; 95% confidence interval [CI]: 0.86-0.96),tranexamic acid (TXA) use (OR: 0.25; 95% CI: 0.09-0.58), andintraoperative autologous blood transfusion from a closed suctiondrainage system (OR: 0.30; 95% CI: 0.09-0.80) were protectiveagainst the need for transfusion in patients after SimBTHA.In addition, drainage use (OR: 3.52; 95% CI: 1.49-8.32) andintraoperative blood loss (OR: 1.17; 95% CI: 1.04-1.33) were theindependent risk factors for blood transfusion. Conclusion: The risk factors for transfusion after SimBTHAshould be evaluated to establish specific, personalized transfusionrisk assessments for each individual patient. For SimBTHA, themain risk factors include intraoperative bleeding and the useof drainage tube, while higher preoperative hemoglobin levels,TXA use, and autologous blood transfusion from a closed suctiondrainage system may reduce transfusion risk.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Diğer Erişim Türü: Erişime Açık

1. Garland A, Rolfson O, Garellick G, Kärrholm J, Hailer NP. Early postoperative mortality after simultaneous or staged bilateral primary total hip arthroplasty: An observational register study from the Swedish Hip Arthroplasty Register. BMC Musculoskelet Disord 2015;16:77.
2. Calabro L, Yong M, Whitehouse SL, Hatton A, de Steiger R, Crawford RW. Mortality and implant survival with simultaneous and staged bilateral total hip arthroplasty: Experience From the Australian Orthopedic Association National Joint Replacement Registry. J Arthroplasty 2020;35:2518-24.
3. Hou JF, Hu C, Zhang Y, Tian LQ, Liu YZ, Zhang C, et al. Cost analysis of staged versus simultaneous bilateral total knee and hip arthroplasty using a propensity score matching. BMJ Open 2021;11:e041147.
4. Guo SJ, Shao HY, Huang Y, Yang DJ, Zheng HL, Zhou YX. Retrospective cohort study comparing complications, readmission, transfusion, and length of stay of patients undergoing simultaneous and staged bilateral total hip arthroplasty. Orthop Surg 2020;12:233-40.
5. Aghayev E, Beck A, Staub LP, Dietrich D, Melloh M, Orljanski W, et al. Simultaneous bilateral hip replacement reveals superior outcome and fewer complications than two-stage procedures: A prospective study including 1819 patients and 5801 follow-ups from a total joint replacement registry. BMC Musculoskelet Disord 2010;11:245.
6. Kamath AF, Austin DC, Derman PB, Clement RC, Garino JP, Lee GC. Saline-coupled bipolar sealing in simultaneous bilateral total knee arthroplasty. Clin Orthop Surg 2014;6:298-304.
7. Bullock DP, Sporer SM, Shirreffs TG Jr. Comparison of simultaneous bilateral with unilateral total knee arthroplasty in terms of perioperative complications. J Bone Joint Surg [Am] 2003;85:1981-6.
8. Bohm ER, Molodianovitsh K, Dragan A, Zhu N, Webster G, Masri B, et al. Outcomes of unilateral and bilateral total knee arthroplasty in 238,373 patients. Acta Orthop 2016;87 Suppl 1:24-30.
9. Edelstein AI, Terzaghi C, Nudelman B, Qin C, Kwasny M, Manning DW. Early response to Warfarin initiation and the risk of venous thromboembolism after total joint arthroplasty. J Am Acad Orthop Surg 2018;26:e90-e97.
10. Jaffer AK, Barsoum WK, Krebs V, Hurbanek JG, Morra N, Brotman DJ. Duration of anesthesia and venous thromboembolism after hip and knee arthroplasty. Mayo Clin Proc 2005;80:732-8.
11. Browne JA, Adib F, Brown TE, Novicoff WM. Transfusion rates are increasing following total hip arthroplasty: Risk factors and outcomes. J Arthroplasty 2013;28(8 Suppl):34-7.
12. Pedersen AB, Mehnert F, Overgaard S, Johnsen SP. Allogeneic blood transfusion and prognosis following total hip replacement: A population-based follow up study. BMC Musculoskelet Disord 2009;10:167.
13. Hart A, Khalil JA, Carli A, Huk O, Zukor D, Antoniou J. Blood transfusion in primary total hip and knee arthroplasty. Incidence, risk factors, and thirty-day complication rates. J Bone Joint Surg [Am] 2014;96:1945-51.
14. Everhart JS, Sojka JH, Mayerson JL, Glassman AH, Scharschmidt TJ. Perioperative allogeneic red blood-cell transfusion associated with surgical site infection after total hip and knee arthroplasty. J Bone Joint Surg [Am| 2018;100:288-94.
15. Taneja A, El-Bakoury A, Khong H, Railton P, Sharma R, Johnston KD, et al. Association between allogeneic blood transfusion and wound infection after total hip or knee arthroplasty: A retrospective case-control study. J Bone Jt Infect 2019;4:99-105.
16. Jiang T, Song K, Yao Y, Pan P, Jiang Q. Perioperative allogenic blood transfusion increases the incidence of postoperative deep vein thrombosis in total knee and hip arthroplasty. J Orthop Surg Res 2019;14:235.
17. Maempel JF, Wickramasinghe NR, Clement ND, Brenkel IJ, Walmsley PJ. The pre-operative levels of haemoglobin in the blood can be used to predict the risk of allogenic blood transfusion after total knee arthroplasty. Bone Joint J 2016;98-B:490-7.
18. Mistry JB, Gwam CU, Naziri Q, Pivec R, Abraham R, Mont MA, et al. Are allogeneic transfusions decreasing in total knee arthroplasty patients? National inpatient sample 2009- 2013. J Arthroplasty 2018;33:1705-12.
19. Slover J, Lavery JA, Schwarzkopf R, Iorio R, Bosco J, Gold HT. Incidence and risk factors for blood transfusion in total joint arthroplasty: Analysis of a statewide database. J Arthroplasty 2017;32:2684-7.
20. Trevisan C, Klumpp R, Auriemma L, Compagnoni R. An algorithm for predicting blood loss and transfusion risk after total hip arthroplasty. Transfus Apher Sci 2018;57:272-6.
21. Cao G, Huang Z, Huang Q, Zhang S, Xu B, Pei F. Incidence and risk factors for blood transfusion in simultaneous bilateral total joint arthroplasty: A multicenter retrospective study. J Arthroplasty 2018;33:2087-91.
22. Salido JA, Marín LA, Gómez LA, Zorrilla P, Martínez C. Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: Analysis of predictive factors. J Bone Joint Surg [Am] 2002;84:216-20.
23. Bemelmans Y, Van Haaren E, Boonen B, Hendrickx R, Schotanus M. Low blood transfusion rate after implementation of tranexamic acid for fast- track hip- and knee arthroplasty. An observational study of 5205 patients. Acta Orthop Belg 2021;87:9-16.
24. Bagsby DT, Samujh CA, Vissing JL, Empson JA, Pomeroy DL, Malkani AL. Tranexamic acid decreases incidence of blood transfusion in simultaneous bilateral total knee arthroplasty. J Arthroplasty 2015;30:2106-9.
25. Wu Y, Yang T, Zeng Y, Si H, Cao F, Shen B. Tranexamic acid reduces blood loss and transfusion requirements in primary simultaneous bilateral total knee arthroplasty: A meta-analysis of randomized controlled trials. Blood Coagul Fibrinolysis 2017;28:501-8.
26. Partridge TCJ, Charity JAF, Sandiford NA, Baker PN, Reed MR, Jameson SS. Simultaneous or staged bilateral total hip arthroplasty? An analysis of complications in 14,460 patients using national data. J Arthroplasty 2020;35:166-71.
27. Palmer AJR, Lloyd TD, Gibbs VN, Shah A, Dhiman P, Booth R, et al. The role of intra-operative cell salvage in patient blood management for revision hip arthroplasty: A prospective cohort study. Anaesthesia 2020;75:479-86.
28. Mayer-Rollnik S, Harms C, Bernasconi L, Hammerer A, Reiss E, Girard T, et al. Evaluation of autologous retransfusion from a closed suction drainage system for patient blood management in elective total hip and knee replacement: A two cohort study. Eur J Anaesthesiol 2020;37:180-6.
29. Klein AA, Bailey CR, Charlton AJ, Evans E, GuckianFisher M, McCrossan R, et al. Association of Anaesthetists guidelines: Cell salvage for peri-operative blood conservation 2018. Anaesthesia 2018;73:1141-50.
30. Niskanen RO, Korkala OL, Haapala J, Kuokkanen HO, Kaukonen JP, Salo SA. Drainage is of no use in primary uncomplicated cemented hip and knee arthroplasty for osteoarthritis: A prospective randomized study. J Arthroplasty 2000;15:567-9.
31. Xu H, Xie J, Lei Y, Huang Q, Huang Z, Pei F. Closed suction drainage following routine primary total joint arthroplasty is associated with a higher transfusion rate and longer postoperative length of stay: A retrospective cohort study. J Orthop Surg Res 2019;14:163.
32. Greenky M, Shaner J, Rasouli MR, Han SB, Parvizi J, Hozack WJ. Intraoperative blood salvage in revision total hip arthroplasty: Who benefits most? J Arthroplasty 2014;29:1298-300.
33. Imai N, Dohmae Y, Suda K, Miyasaka D, Ito T, Endo N. Tranexamic acid for reduction of blood loss during total hip arthroplasty. J Arthroplasty 2012;27:1838-43.
34. Abdelaziz H, Chaabene A, Schulmeyer J, Gehrke T, Haasper C, Hawi N, et al. Intravenous tranexamic acid is associated with safe reduced blood loss and transfusion rate in onestage exchange for infected hip arthroplasty. Jt Dis Relat Surg 2021;32:17-21.

APA	wang x, Huang Q, Pei F (2021). Incidence and risk factors for blood transfusion insimultaneous bilateral total hip arthroplasty. , 590 - 597. 10.52312/jdrs.2021.333
Chicago	wang xing,Huang Qiang、,Pei Fuxing Incidence and risk factors for blood transfusion insimultaneous bilateral total hip arthroplasty. (2021): 590 - 597. 10.52312/jdrs.2021.333
MLA	wang xing,Huang Qiang、,Pei Fuxing Incidence and risk factors for blood transfusion insimultaneous bilateral total hip arthroplasty. , 2021, ss.590 - 597. 10.52312/jdrs.2021.333
AMA	wang x,Huang Q,Pei F Incidence and risk factors for blood transfusion insimultaneous bilateral total hip arthroplasty. . 2021; 590 - 597. 10.52312/jdrs.2021.333
Vancouver	wang x,Huang Q,Pei F Incidence and risk factors for blood transfusion insimultaneous bilateral total hip arthroplasty. . 2021; 590 - 597. 10.52312/jdrs.2021.333
IEEE	wang x,Huang Q,Pei F "Incidence and risk factors for blood transfusion insimultaneous bilateral total hip arthroplasty." , ss.590 - 597, 2021. 10.52312/jdrs.2021.333
ISNAD	wang, xing vd. "Incidence and risk factors for blood transfusion insimultaneous bilateral total hip arthroplasty". (2021), 590-597. https://doi.org/10.52312/jdrs.2021.333

APA	wang x, Huang Q, Pei F (2021). Incidence and risk factors for blood transfusion insimultaneous bilateral total hip arthroplasty. Joint diseases and related surgery, 32(3), 590 - 597. 10.52312/jdrs.2021.333
Chicago	wang xing,Huang Qiang、,Pei Fuxing Incidence and risk factors for blood transfusion insimultaneous bilateral total hip arthroplasty. Joint diseases and related surgery 32, no.3 (2021): 590 - 597. 10.52312/jdrs.2021.333
MLA	wang xing,Huang Qiang、,Pei Fuxing Incidence and risk factors for blood transfusion insimultaneous bilateral total hip arthroplasty. Joint diseases and related surgery, vol.32, no.3, 2021, ss.590 - 597. 10.52312/jdrs.2021.333
AMA	wang x,Huang Q,Pei F Incidence and risk factors for blood transfusion insimultaneous bilateral total hip arthroplasty. Joint diseases and related surgery. 2021; 32(3): 590 - 597. 10.52312/jdrs.2021.333
Vancouver	wang x,Huang Q,Pei F Incidence and risk factors for blood transfusion insimultaneous bilateral total hip arthroplasty. Joint diseases and related surgery. 2021; 32(3): 590 - 597. 10.52312/jdrs.2021.333
IEEE	wang x,Huang Q,Pei F "Incidence and risk factors for blood transfusion insimultaneous bilateral total hip arthroplasty." Joint diseases and related surgery, 32, ss.590 - 597, 2021. 10.52312/jdrs.2021.333
ISNAD	wang, xing vd. "Incidence and risk factors for blood transfusion insimultaneous bilateral total hip arthroplasty". Joint diseases and related surgery 32/3 (2021), 590-597. https://doi.org/10.52312/jdrs.2021.333